Redefining FL Treatment with Bispecific Antibodies - CME

CME

Description: While bispecific antibodies are emerging as an important therapeutic option in follicular lymphoma (FL), there is still uncertainty about their evolving roles across the treatment continuum. Confusion also exists about optimal patient selection, how these agents fit into the current FL treatment landscape, and the strength of evidence supporting their use in both relapsed/refractory and frontline settings. Join us for a CME activity that will provide practical, evidence-based guidance on the use of bispecific antibodies in FL. Through case-based learning, participants will examine the latest clinical data and improve the recognition, monitoring, and management of treatment-related adverse events. Faculty will share team-based strategies for early identification, grading, and intervention to support patient safety, treatment continuity, and improved outcomes.

Target Audience: The primary target audience for this activity are hematologists/oncologists, nurses/nurse practitioners, physician assistants, and other health care professionals.

Learning Objectives

Assess the role of bispecific antibodies in the treatment of relapsed/refractory follicular lymphoma
Examine the clinical rationale and evidence supporting the use of bispecific antibodies in frontline follicular lymphoma
Outline team-based strategies to recognize and manage adverse events associated with bispecific antibodies

Disclosures and Disclaimers: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AMA PRA Category 1 Credit	1 Credits	ACCME- Accreditation Council for Continuing Medical Education